Mechanisms of osteoclast dysfunction in human osteopetrosis: Abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures

Journal of Bone and Mineral Research

Volumn 14, Issue 12, 1999, Pages 2107-2117

  Teti, Anna ^a,f   Migliaccio, Silvia ^b   Taranta, Anna ^b,c   Bernardini, Silvia ^b,e   De Rossi, Giulio ^d   Luciani, Matteo ^d   Iacobini, Metello ^b   De Felice, Lidia ^b   Boldrini, Renata ^d   Bosman, Cesare ^e   Corsi, Alessandro ^a   Bianco, Paolo ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; CALCITONIN RECEPTOR; GELATINASE B; INTEGRIN; STEROID HORMONE; VITRONECTIN RECEPTOR;

ALBERS SCHOENBERG DISEASE; ARTICLE; CASE REPORT; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE SRC; OSTEOCLAST; OSTEOLYSIS; SCHOOL CHILD;

EID: 17144463459     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.12.2107     Document Type: Article

References (62)

1. Mundy GR 1987 Osteopetrosis. In: Stein JH (ed.) Internal Medicine. Little, Brown, Boston, MA, U.S.A., pp. 2115-2117.
2. Teitelbaum SL 1993 Molecular defects of bone development. In: Favus MJ (ed.) Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Lippincott Raven Publisher, Philadelphia, PA, U.S.A., pp. 10-15.
3. Whyte MP 1996 Sclerosis bone dysplasias. In: Favus MJ (ed.) Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Lippincott Raven Publisher, Philadelphia, PA, U.S.A., pp. 363-379.
4. Loria-Cortes R, Quesada-Calvo E, Cordero-Chaverri E 1977 Osteopetrosis in children: A report of 26 cases. J Pediatr 91:43-47.
5. Kaplan FS, August CS, Fallon MD, Dalinka M, Axel L, Haddad JG 1988 Successful treatment of infantile malignant osteopetrosis by bone marrow transplantation: A case report. J Bone Joint Surg 70:617-623.
6. Beard CJ, Key L, Newburger PE, Ezekowitz RA, Arceri R, Miller B, Proto P, Ryan T, Anast C. Simons ER 1986 Neutrophil defect associated with malignant infantile osteopetrosis. J Lab Clin Med 108:498-505.
7. Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, Kim TH, Nesbit ME, Ramsay NK, Warkentin P, Teitelbaum SL, Kahn AJ, Brown DM 1980 Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 302:701-708.
8. Johnston CC Jr, Lavy N, Lord T, Vellios F, Merrit AD, Deiss WP 1968 Osteopetrosis: A clinical, genetic, metabolic and morphologic study of the dominant inherited benign form. Medicine 47:149-167.
9. Bollerslev J, Mosekilde L 1993 Autosomal dominant osteopetrosis. Clin Orthop 294:45-51.
10. Grodum E, Gram J, Brixen K, Bollerslev J 1995 Autosomal dominant osteopetrosis: Bone mineral measurements of the entire skeleton of adults in two different subtypes. Bone 16:431-434.
11. Van Hul W, Bollerslev J, Gram J, Van Hul E, Wuyts W, Berichou O, Vanhoeanacker F, Willems PJ 1997 Localization of a gene for autosomal dominant osteopetrosis (Albers-Schonberg disease) to chromosome 1p21. Am J Human Genet 61:363-369.
12. Kahler SG, Burns JA, Aylsworth AS 1984 A. mild autosomal recessive form of osteopetrosis. Am J Med Genet 17:451-464.
13. Whyte MP 1993 Carbonic anhydrase II deficiency. Clin Orthop 294:52-63.
14. Sly WS, Hewett-Emmet D, Whyte MP, Yu Y-SL, Tashian RE 1983 Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 80:2752-2756.
15. Sly WS, Hu PY 1995 The carbonic anhydrase deficiency syndrome: Osteopetrosis with renal tubular acidosis and cerebral calcification. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, NY, U.S.A., pp. 4113-4124.
16. + ATPase. J Clin Invest 93:2311-2318.
17. Venta PJ, Welty RJ, Johnson TM, Sly WS, Tashian RE 1991 Carbonic anhydrase deficiency syndrome in a Belgian family is caused by a point mutation at an invariant histidine residue (107 His→Tyr): Complete structure of the normal human CA II gene. Am J Hum Genet 49:1082-1090.
18. Roth DE, Venta PJ, Tashian RE, Sly WS 1992 Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci USA 89:804-1808.
19. Walker DG 1975 Control of bone resorption by hematopoietic tissue: The induction and reversal of congenital osteopetrosis in mice through the use of bone marrow mononuclear phagocytes. J Exp Med 156:1604-1614.
20. Marks SC Jr 1989 Osteoclast biology: lessons from mammalian mutations. Am J Med Genet 34:43-54.
21. Wiktor-Jedrzeiezak W, Bartocci A, Ferrante AW, Ahmed-Ansari A Jr, Sell KW, Pollard JW, Stanley ER 1990 Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 87:4828-4832.
22. Felix R, Cecchini MG, Hofstetter W, Elfors PR, Stutzer A, Fleisch H 1990 Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 5:781-789.
23. Suda T, Nakamura I, Jimi E, Takahashi N 1997 Regulation of osteoclast function. J Bone Miner Res 12:869-879.
24. Yoshida H, Hayashi S-I, Kunisada T, Ogawa M, Nishikawa S, Okamura M, Sudo T, Shultz LD, Nishikawa S-I 1990 The murine mutation osteopetrosis is in the coding region of the macrophage colony-stimulating factor gene. Nature 345:442-444.
25. Soriano P, Montgomery C, Geske R, Bradley A 1991 Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
26. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622-1627.
27. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P 1993 Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 90:4485-4489.
28. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF 1994 c-fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448.
29. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL 1997 Osteopetrosis in mice lacking haemopoietic transcription factor PU.1. Nature 386:81-84.
30. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R 1997 Osteopetrosis in mice lacking NF-κB1 and NF-KB2. Nat Med 3:1285-1289.
31. Shalboud V, Jackson ME, Lian JB, Stein GS, Marks SC Jr 1991 Gene expression during skeletal development in three osteopetrotic rat mutations: Evidence for osteoblast abnormalities. J Biol Chem 266:9847-9856.
32. Chackalaparampil I, Peri A, Nemir M, Mckee MD, Lin P-H, Mukherjee BB, Mukherjee AB 1996 Cells in vivo and in vivo from osteopetrotic mice homozygous for c-src disruption show suppression of synthesis of osteopontin, a multifunctional extracellular matrix protein. Oncogene 12:1457-1467.
33. Shalboud V, Jackson ME, Paradise C, Stein GS, Lian JB, Marks SC Jr 1902 Heterogeneity of colony stimulating factor-1 gene expression in the skeleton of four osteopetrotic mutations in rats and mice. J Cell Physiol 166:340-350.
34. MacDonald BR, Takahashi N, McManus LM, Holahan J, Mundy GR, Roodman GD 1987 Formation of multinucleated cells that respond to osteotropic hormones in long-term human bone marrow cultures. Endocrinology 120:2326-2333.
35. Caselli GF, Mantovanini M, Gandolfi CA, Allegretti M, Fiorentino S, Pellegrini L, Melillo G, Bertini R, Sabbatini W, Anacardio R, Clavenna G, Sciortino G, Teti A 1997 Tartronates: A new generation of drugs affecting bone metabolism. J Bone Miner Res 12:972-981.
36. Teti A, Marchisio PC, Zambonin Zallone A 1991 Clear zone in osteoclast function: Role of podosomes in regulation of bone-resorbing activity. Am J Physiol 261:C1-C7.
37. Vaananen HK, Horton MA 1995 The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J Cell Sci 108:2729-2732.
38. Marchisio PC, Naldini L, Cirillo D, Primavera MV, Teti A, Zambonin Zallone A 1984 Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. J Cell Biol 99:1696-1705.
39. Marchisio PC, Cirillo D, Teti A, Zambonin Zallone A, Tarone G 1987 Rous sarcoma virus transformed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytoskeletal proteins involved in microfilament-membrane interactions. Exp Cell Res 169:202-214.
40. 3 integrin is colocalized with vinculin and talin in the podosomes of osteoclastoma giant cells. Exp Cell Res 182:645-652.
41. Kanehisa J, Yamanaka T, Doi S, Heersche JNM 1990 A. band of F-actin containing podosomes is involved in bone resorption by osteoclasts. J Bone Miner Res 5:287-293.
42. Lakkakorpi P, Tukkanen J, Huntunen T, Jarvelin K, Vaananen HK 1989 Organization of osteoclast microfilaments during the attachment to bone surface in vitro. J Bone Miner Res 4:817-825.
43. Lakkakorpi P, Vaananen HK 1991 Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J Bone Miner Res 6:817-826.
44. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton MA 1989 The osteoclast functional antigen implicated in the regulation of bone resorption is biochemically related to the vitronectin receptor. J Cell Biol 109:1817-1826.
45. 3 integrin subunits in rat osteoclasts in situ. J Bone Miner Res 4:403-414.
46. Horton MA, Taylor ML, Arnett TR, Helfrich MH 1991 Arg-Gly.Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 195:368-375.
47. Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RJ, Garsky VM, Rodan GA, Rosenblatt M 1993 Inhibition of osteoclastic bone resorption in vivo by echistatin, an 'arginylglycyl-aspartyl' (RGD)-containing protein. Endocrinology 132:1411-1413.
48. Rodan SB, Rodan GA 1997 Integrin function in osteoclasts. J Endocrinol 154:S47-S56.
49. 3, integrin 'vitronectin receptor'. Int J Biochem Cell Biol 29:721-725.
50. Insogna K, Tanak S, Neff L, Home W. Leby J, Baron R 1997 Role of c-src in cellular events associated with colony-stimulating factor 1-induced spreading in osteoclasts. Mol Reprod Dev 46:104-108.
51. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ 1993 Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178:1733-1744.
52. Teti A, Taranta A, Migliaccio S, DeGiorgi A, Santandrea E, Villanova I, Faraggiana T, Chellaiah M, Hruska KA 1998 Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene. J Bone Miner Res 13:50-58.
53. Hofstetter W, Wetterwald A, Cecchini MG, Felix R, Fleisch H, Mueller C 1992 Detection of transcript for the receptor for macrophage colony stimulating factor, c-fms, in murine osteoclasts. Proc Natl Acad Sci USA 89:9637-9641.
54. Athanasou NA, Alvarez JI, Ross FP, Quinn JM, Teitelbaum SL 1992 Species differences in the immunophenotype of osteoclasts and mononudear phagocytes. Calcif Tissue Int 50:427-432.
55. 3 induces differentiation of osteoclast-like cells from human bone marrow cultures. Biochem Biophys Res Commun 176:1189-1195.
56. Roodman GD 1996 Advances in bone biology: The osteoclast. Endocr Rev 17:308-332.
57. 3. J Bone Miner Res 8:61-70.
58. Chambers TJ, McSheehy PMJ, Thompson BM, Fuller K 1985 The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclast disaggregated from rabbit long bones. Endocrinology 116:234-239.
59. Gravel MR, Zheng ZG, Sims SM, Dixon SJ 1994 Platelet-activating factor induces pseudopod formation in calcitonin-treated rabbit osteoclasts. J Bone Miner Res 9:1769-1776.
60. Gilmore AP, Burridge K 1996 Molecular mechanisms for focal adhesion assembly through regulation of protein-protein interactions. Structure 4:647-651.
61. Stickel SK, Wang YL 1987 Alpha actinin-containing aggregates in transformed cells are highly dynamic structures. J Cell Biol 104:1521-1526.
62. Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB, Baron R 1996 c-cbl is downstream of c-src in a signalling pathway necessary for bone resorption. Nature 383:528-531.